BIVALIRUDIN;BITTERMELONP.E;BivalirudinTFA;Human Bivalirudin;Bivalirudin AcetateBG 8967,;Hirulog,;Hirulog I;BIVALIRUDIN TRIFLUOROACETATE;Hirulog trifluoroacetate salt;Bivalirudin trifluoroacetate salt;Bivalirudin BG 8967,;Hirulog, Hirulog I;H-D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH;H-D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH trifluoroacetate salt;D-Phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-aspariginylglycyl-L-?-aspartyl-L-phenylalanyl-L-?-glutamyl-L-?-glutamyl-L-isoleucyl-L-prolyl-L-?-glutamyl-L-?-glutamyl-L-tyrosyl-L-leucine trifluoroacetate.
Bivalirudin is a fully characterized chemical compound used as a reference standard of API Bivalirudin. The standard offered is compliant with regulatory guidelines. Bivalirudin is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 128270-60-0
![Picture of Bivalirudin Impurity ([Beta-Asp9]-Bivalirudin)](https://bc3c83a0874864a50753-7010fd7f2bdf81ab41ee28479491701e.ssl.cf2.rackcdn.com/media//catalog/AR-B01795.jpg?size=256 "Show details for Bivalirudin Impurity ([Beta-Asp9]-Bivalirudin)")
![Picture of [9,10]-Cyclo Bivalirudin](https://bc3c83a0874864a50753-7010fd7f2bdf81ab41ee28479491701e.ssl.cf2.rackcdn.com/media//catalog/AR-B01802.jpg?size=256 "Show details for [9,10]-Cyclo Bivalirudin")
